Concepedia

Hormas Ghadially

HG

Statistics

Publications

19

Citations

1.2K

H-Index

16

Active since

1999

Affiliations

AstraZeneca (United Kingdom)(Current)

University of Cambridge

Hadassah Medical Center

Concern Foundation

Hebrew University of Jerusalem

Hormas Ghadially is an author at AstraZeneca (United Kingdom) specializing in immunology, life sciences, and natural killer cell biology.

ORCID

Publications per year

1999–2023

19

Publications

19

The activating receptor NKp46 is essential for the development of type 1 diabetes

Chamutal Gur, Angel Porgador, Moran Elboim et al. · Nature Immunology · 2009 · 172 citations

, , +9

Recognition and Prevention of Tumor Metastasis by the NK Receptor NKp46/NCR1

Ariella Glasner, Hormas Ghadially, Chamutal Gur et al. · The Journal of Immunology · 2012 · 167 citations

, , +13

Distinctive phenotypes and functions of innate lymphoid cells in human decidua during early pregnancy

Oisín Huhn, Martin A. Ivarsson, Lucy Gardner et al. · Nature Communications · 2020 · 160 citations · Full text

, , +17

Enhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR1

Gili G. Halfteck, Moran Elboim, Chamutal Gur et al. · The Journal of Immunology · 2009 · 149 citations · Full text

, , +16

MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue

Hormas Ghadially, Lee R. Brown, Chris J. Lloyd et al. · British Journal of Cancer · 2017 · 111 citations · Full text

, , +17

1–5 of 19